Evidence map›Paper›PMID 36233161›Full record

ArticleInternational journal of molecular sciences2022

Mutations, Genes, and Phenotypes Related to Movement Disorders and Ataxias.

Dolores Martínez-Rubio, Isabel Hinarejos, Paula Sancho, Nerea Gorría-Redondo, Raquel Bernadó-Fonz, Cristina Tello, Clara Marco-Marín, Itxaso Martí-Carrera, María Jesús Martínez-González, Ainhoa García-Ribes and 22 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Cold Spring Harbor molecular case studies · 2023
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 16 institutions in 3 countries.

Dolores Martínez-RubioRare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
Isabel HinarejosRare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
Paula SanchoRare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
Nerea Gorría-RedondoPaediatric Neurology Unit, Department of Paediatrics, Hospital Universitario de Navarra, Navarrabiomed, 31008 Pamplona, Spain.
Raquel Bernadó-FonzPaediatric Neurology Unit, Department of Paediatrics, Hospital Universitario de Navarra, Navarrabiomed, 31008 Pamplona, Spain.
Cristina TelloRare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
Clara Marco-MarínStructural Enzymopathology Unit, Instituto de Biomedicina de Valencia (IBV), Consejo Superior de Investigaciones Científicas (CSIC), Centro de Investigación Biomédica de Enfermedades Raras (CIBERER-ISCIII), 46010 Valencia, Spain.
Itxaso Martí-CarreraBiodonostia Health Research Institute, Paediatric Group, Donostia University Hospital, Department of Paediatrics, University of the Basque Country UPV/EHU, 20014 San Sebastian, Spain.
María Jesús Martínez-GonzálezPaediatric Neurology Unit, Hospital Universitario Cruces, 48903 Barakaldo, País Vasco, Spain.
Ainhoa García-RibesPaediatric Neurology Unit, Hospital Universitario Cruces, 48903 Barakaldo, País Vasco, Spain.
Raquel Baviera-MuñozJoint Unit CIPF-IIS La Fe Rare Diseases, 46012 Valencia, Spain.
Isabel Sastre-BatallerJoint Unit CIPF-IIS La Fe Rare Diseases, 46012 Valencia, Spain.
Irene Martínez-TorresJoint Unit CIPF-IIS La Fe Rare Diseases, 46012 Valencia, Spain.
Anna Duat-RodríguezPaediatric Neurology Unit, Hospital Infantil Universitario Niño Jesús, 28009 Madrid, Spain.
Patrícia JaneiroCentro de Referencia de Doenças Hereditarias do Metabolismo, CHULN, Hospital Santa Maria, 1649-035 Lisbon, Portugal.
Esther MorenoDepartment of Paediatrics, Hospital Regional Universitario, 29010 Malaga, Spain.
Leticia Pías-PeleteiroPaediatric Neurology Unit, Hospital Sant Joan de Déu, 08950 Barcelona, Spain.
Mar O'Callaghan GordoPaediatric Neurology Unit, Hospital Sant Joan de Déu, 08950 Barcelona, Spain.
Ángeles Ruiz-GómezDepartment of Paediatrics, Hospital Universitari Son Espases, 07120 Palma de Mallorca, Spain.
Esteban MuñozUnit of Parkinson and Movement Disorders, Department of Neurology, Hospital Universitari Clínic, 08036 Barcelona, Spain.
Maria Josep MartíUnit of Parkinson and Movement Disorders, Department of Neurology, Hospital Universitari Clínic, 08036 Barcelona, Spain.
Ana Sánchez-MonteagudoRare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
Candela FusterRare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
Amparo Andrés-BorderíaRare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
Roser Maria PonsPaediatric Neurology, Hospital Agia Sofía, 11527 Athens, Greece.
Silvia Jesús-MaestreMovement Disorders Unit, Department of Neurology and Clinical Neurophysiology, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED-ISCIII), 41013 Seville, Spain.
Pablo MirMovement Disorders Unit, Department of Neurology and Clinical Neurophysiology, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED-ISCIII), 41013 Seville, Spain.
Vincenzo LupoRare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .
Belén Pérez-DueñasDepartment of Paediatric Neurology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, 08035 Barcelona, Spain.
Alejandra DarlingPaediatric Neurology Unit, Hospital Sant Joan de Déu, 08950 Barcelona, Spain.
Sergio Aguilera-AlbesaPaediatric Neurology Unit, Department of Paediatrics, Hospital Universitario de Navarra, Navarrabiomed, 31008 Pamplona, Spain.
Carmen EspinósRare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe (CIPF), 46012 Valencia, Spain .ORCID 0000-0003-4435-1809
Centro de Investigacion Principe Felipe · ESHospital Sant Joan de Déu Barcelona · ESHospital Universitari i Politècnic La Fe · ESNavarrabiomed · ESHospital de Cruces · ESHospital Universitari de Vic · ESInstituto de Salud Carlos III · ESAgia Olga Hospital · GRConsejo Superior de Investigaciones Científicas · ESHospital de Santa Maria · PTHospital Infantil Universitario Niño Jesús · ESHospital Regional Universitario de Málaga · ESHospital Universitario Son Espases · ESUniversity of the Basque Country · ESValencia Catholic University Saint Vincent Martyr · ESVall d'Hebron Institut de Recerca · ES

Funding

Fundació la Marató de la TV3 20143130Fundació La Marató de la TV3 20143131Fundació Per Amor a l'Art FPAA-WilsonGeneralitat Valenciana PROMETEO/2018/135Instituto de Salud Carlos III FI19/00072Instituto de Salud Carlos III PI18/00147Instituto de Salud Carlos III PI21/00103Ministerio de Educación Cultura y Deporte FPU15/00964
6 · The paper itself

Abstract

Our clinical series comprises 124 patients with movement disorders (MDs) and/or ataxia with cerebellar atrophy (CA), many of them showing signs of neurodegeneration with brain iron accumulation (NBIA). Ten NBIA genes are accepted, although isolated cases compatible with abnormal brain iron deposits are known. The patients were evaluated using standardised clinical assessments of ataxia and MDs. First, NBIA genes were analysed by Sanger sequencing and 59 patients achieved a diagnosis, including the detection of the founder mutation PANK2 p.T528M in Romani people. Then, we used a custom panel MovDisord and/or exome sequencing; 29 cases were solved with a great genetic heterogeneity (34 different mutations in 23 genes). Three patients presented brain iron deposits with Fe-sensitive MRI sequences and mutations in

Indexed as

Movement DisordersNeurodegenerative DiseasesAtaxiaBrainHumansIronKinesinsMutationPhenotypePhosphotransferases (Alcohol Group Acceptor)IronKIF1A protein, humanKinesinsPhosphotransferases (Alcohol Group Acceptor)ataxiacerebellar atrophyexome sequencinggene panelmovement disordersneurodegeneration with brain iron accumulation (NBIA)

Identifiers

PMID36233161
PMCPMC9570320
OpenAlexW4303699581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.